Pharmapack 2021 opens entries for Patient-Centric Design Awards
The global pandemic continues to impact lots of industries and slow down business, but the pharma and packaging industries are striving to tackle new challenges to bring more faster and safer solutions to deliver medication to patients. The Pharmapack Awards continue to recognize companies which have invested in innovating to improve patient outcomes, while working within the confines of a highly regulated pharma industry and changing business model.
Launched in 1997, the Pharmapack Awards recognize all types of innovations in the field of pharmaceutical packaging and drug delivery devices which have significantly improved drug efficacy and user’s safety and addressed sustainability issues such as a reduced impact on the environment.
In the Health Product Category*, Pharmapack has partnered with HCPC (Healthcare Compliance Packaging Council) Europe to set up the “Patient-centric Design Award” to select outstanding patient-friendly, or patient-centric packaging or drug delivery solutions.
At Pharmapack Europe 2020, the Patient-centric Design Award was won by Creon® SD, developed by Abbott Healthcare Pvt Limited, a smart granule dosing device for dispensing of Pancreatin Mini-microspheres.
See the Pharmapack 2020 Winners list
Additionally, more than ten new patient-centric concepts were showcased in the Pharmapack Innovation Gallery. Two smart drug delivery devices, from Credence MedSystems and Nemera, and a Patient Support App from Rondo were rewarded in the Exhibitors’ innovation category by the Pharmapack 2020 Awards jury.
Watch the video of Pharmapack Awards 2020 Winners’ presentations
Pharmapack opens entries of Patient-centric Design Award for all pharma and medical companies who have launched a new health product with a patient-centric design with market authorisation after December 2019. The deadline for submitting your candidature is 9 April 2021.
The Awards ceremony will be held on the first day of Pharmapack 2021, with the conference and exhibition taking place from 19-20 May in Paris Expo, Porte des Versailles.
Related News
-
News mRNA therapy for ovarian cancer and muscle wasting
Researchers demonstrate results of a promising mRNA therapy for ovarian cancer and muscle wasting caused by cachexia, a condition associated with various types of cancers and chronic diseases. -
News Pfizer CentreOne Content Refinement Q3 media buy
For 40 years Pfizer CentreOne has been guiding drug projects to success. Here’s how our services make us an altogether different kind of CDMO: -
News Bora Pharmaceuticals expands development and manufacturing capacity with landmark acquisition
Taiwan-based CDMO Bora Pharmaceuticals have acquired niche generic drugs developer TWi Pharmaceuticals, expanding their outsourced development and manufacturing services with two additional manufacturing facilities. -
News Lonza and Touchlight collaboration to bring expanded end-to-end mRNA offerings
Through a collaboration with biotech company Touchlight, Lonza is set to expand their end-to-end offering for mRNA manufacturing with additional DNA raw material sources, including Touchlight’s doggybone DNA. -
News Oxford University presents promising phase II data for malaria vaccine
The malaria vaccine R21/Matrix-M, developed by researchers at Oxford University, has produced encouraging new data for the global effort against the mosquito-borne disease. -
News NextPharma to acquire Norway manufacturing site from Takeda
Biopharmaceutical company Takeda and CDMO NextPharma have announced an acquisition agreement in which Takeda will divest from their Asker, Norway manufacturing site, set to be acquired by NextPharma. -
News Gut instinct: molecular link between COVID-19 and serotonin cells in the gut
New research may provide further evidence of the gut’s role in SARS-CoV-2 infection and disease severity with a molecular link between serotonin-producing cells in the gut and COVID-19 disease severity. -
News Novavax COVID-19 vaccine receives backing from European Medicines Agency
The European Medicines Agency has backed the Nuvaxovid COVID-19 vaccine for adults as a booster shot to other COVID-19 vaccines.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance